Live feed
Filing
SC 13D/A
SC 13D/A0001104659-24-048469·Outlook Therapeutics, Inc.
Schedule 13D ownership disclosure
OUTLOOK THERAPEUTICS INC
Security class unavailable · CUSIP: 69012T305
Event date: 2024-04-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,776,867
- Percent of class
- 11.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-048469
- Form type
- SC 13D/A
- Filer
- Outlook Therapeutics, Inc.
- CIK
- CIK 1649989
- Filed
- Apr 17, 2024
- Reporting period
- Apr 15, 2024
- Description
- Schedule 13D beneficial ownership